Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Irene Vanni(Ospedale Policlinico San Martino), Paola Ghiorzo(Ospedale Policlinico San Martino), William Bruno(Ospedale Policlinico San Martino), Bruna Dalmasso(Ospedale Policlinico San Martino), Francesco Spagnolo(Martin University), Virginia Andreotti(University of Genoa), Enrica T. Tanda(Ospedale Policlinico San Martino), Andrea Boutros(The University of Sydney), Lorenza Pastorino(Ospedale Policlinico San Martino)
Cited by 37
Related Papers
Genome-wide association study identifies three new melanoma susceptibility loci
|Nature Genetics|2011|250
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
|Nature Genetics|2015|245
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
|Nature Genetics|2020|238
Common sequence variants on 20q11.22 confer melanoma susceptibility
|Nature Genetics|2008|226
The treatment of advanced melanoma: Current approaches and new challenges
|Critical Reviews in Oncology/Hematology|2024|140